Adalimumab May Be Helpful for Juvenile Rheumatoid Arthritis
Adalimumab may be effective for the treatment of children with juvenile rheumatoid arthritis, according to the results of a study reported in the August 21 issue of the New England Journal of Medicine. “Tumor necrosis factor (TNF) has a pathogenic role in juvenile rheumatoid arthritis,” write Daniel J. Lovell, MD, MPH, at Cincinnati Read More This Entry